This initial finding, and the subsequent replication in numerous patient cohorts [4]–[10], marked an important break-through in our understanding of SLE pathogenesis given the critical role of IRF5 in regulating type I IFN expression and mediating Toll-like receptor (TLR) signaling [11]–[14]. This evidence concerns the gene IRF5 and systemic lupus erythematosus.